Resistome, virulome and phage defense systems of a hypervirulent XDR Pseudomonas aeruginosa ST357
Academia Molecular Biology and Genomics · 02.07.2026 · 3 (3)
DOI: 10.20935/acadmolbiogen8405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Molecular Biology and Genomics, online erschienen am 02.07.2026. Verfasst von Alessandro M. Santos und 6 weiteren Autor:innen. Die Arbeit nennt 76 Literaturangaben.
Abstract (Originalsprache)
Introduction
We aimed to perform a comprehensive genomic and phenotypic characterization of Pseudomonas aeruginosa clinical isolate ID-047/23, focusing on its resistance mechanisms, virulence factors, and defense systems against mobile genetic elements (MGEs). Materials and methods: The study utilized phenotypic antimicrobial susceptibility testing and high-throughput genomic sequencing to identify the sequence type (ST), resistome, virulome, and presence of MGEs and defense systems.
Results
Lineage and Resistance: Isolate ID-047/23 was identified as the high-risk clone ST357 with an extensively drug-resistant (XDR) profile, susceptible only to polymyxin B. Genomic analysis revealed a complex resistome featuring the carbapenemase gene blaNDM-1 (within a Tn125 transposon) and the extended-spectrum β-lactamase (ESBL) gene blaVEB-1. This represents a unique co-occurrence for this lineage in Brazil. In terms of virulence and persistence, the isolate carries a hypervirulent genotype (exoU+/exoS-), Type III and VI secretion systems, and biofilm determinants (pel, psl). Pathogenicity is further enhanced by the integration of Pseudomonas aeruginosa pathogenicity island 1 (PAPI-1) and Pseudomonas aeruginosa pathogenicity island 2 (PAPI-2). The detection of active Type I-F clustered regularly interspaced short palindromic repeats (CRISPR) and associated proteins (Cas) (CRISPR-Cas) and restriction-modification (R-M) systems indicates a robust, multi-layered defense against foreign DNA.
Conclusions
Isolate ID-047/23 is a highly adaptable and virulent XDR clone. The presence of sophisticated anti-phage defense systems suggests significant barriers to developing phage-based therapies. These findings underscore the urgent need for enhanced surveillance and the development of alternative therapeutic strategies to manage high-risk P. aeruginosa clones.
Zitieren
APA
Santos, A. M., Camargo, C. H., Yamada, A. Y., Campos, K. R., Sacchi, C. T., Vila, M. M. D. C., & Balcão, V. M. (2026). Resistome, virulome and phage defense systems of a hypervirulent XDR Pseudomonas aeruginosa ST357. Academia Molecular Biology and Genomics, 3(3). https://doi.org/10.20935/acadmolbiogen8405
Vancouver
Santos AM, Camargo CH, Yamada AY, Campos KR, Sacchi CT, Vila MMDC, et al. Resistome, virulome and phage defense systems of a hypervirulent XDR Pseudomonas aeruginosa ST357. Academia Molecular Biology and Genomics. 2026;3(3). doi:10.20935/acadmolbiogen8405
BibTeX
@article{Santos2026,
author = {Santos, Alessandro M. and Camargo, Carlos H. and Yamada, Amanda Y. and Campos, Karoline R. and Sacchi, Claudio T. and Vila, Marta M. D. C. and Balcão, Victor M.},
title = {Resistome, virulome and phage defense systems of a hypervirulent XDR Pseudomonas aeruginosa ST357},
journal = {Academia Molecular Biology and Genomics},
year = {2026},
volume = {3},
number = {3},
doi = {10.20935/acadmolbiogen8405}
}
EUVIMED